Based on the CDC's FluView Summary for the week ending January 13, 2024, here are the key facts:

1. Seasonal Influenza Activity: Influenza activity remains elevated in most parts of the country.

2. Viruses: In clinical labs, 13.7% of respiratory specimens tested positive for influenza. The most frequently reported influenza viruses were influenza A(H1N1)pdm09.

3. Virus Characterization: CDC performed genetic and antigenic characterization of U.S. viruses, finding the circulating strains to be well-recognized by current influenza vaccines.

4. Outpatient Respiratory Illness: 4.7% of visits to healthcare providers were for respiratory illness, above the national baseline of 2.9%. All regions had decreased ILI activity compared to the previous week but remained above their region-specific baselines.

5. Geographic Spread: Four states reported local flu activity, while the majority reported sporadic activity or no activity.

6. FluSurv-NET Hospitalizations: There have been a total of 11,414 laboratory-confirmed influenza-associated hospitalizations between October 1, 2023, and January 13, 2024. The weekly hospitalization rate was 3.2 per 100,000 population.

7. Pneumonia and Influenza (P&I) Mortality: 1.2% of deaths during Week 2 were attributed to influenza, below the epidemic threshold.

8. Pediatric Deaths: Seven influenza-associated pediatric deaths were reported during Week 2, bringing the total for the season to 47.

9. Vaccination Recommendation: CDC recommends that everyone 6 months and older get an annual flu vaccine.

Please note that all data mentioned are preliminary and may change as more reports are received.